Dec. 12 at 11:15 PM
$HAO It’s interesting that Haoxi Health Technology has received shareholder approval for a reverse split, yet the exact ratio and effective date remain unknown. That uncertainty actually adds an element of anticipation, and given the low float and potential for renewed market attention, this setup could easily spark a massive run once the board announces the specifics. Traders often react strongly to the combination of authorization plus speculation, so keeping an eye on when the split is officially declared could be key for anyone looking to capitalize on the move.
